Reason for clozapine cessation

  1. N. B. Pai1,2,
  2. S. C. Vella2

Article first published online: 24 OCT 2011

DOI: 10.1111/j.1600-0447.2011.01776.x

Issue

Acta Psychiatrica Scandinavica

Acta Psychiatrica Scandinavica

Volume 125, Issue 1, pages 39–44, January 2012

Additional Information

How to Cite

Pai, N. B. and Vella, S. C. (2012), Reason for clozapine cessation. Acta Psychiatrica Scandinavica, 125: 39–44. doi: 10.1111/j.1600-0447.2011.01776.x

Author Information

  1. 1

    Illawarra Health Medical Research Institute, University of Wollongong

  2. 2

    Graduate School of Medicine, University of Wollongong, New South Wales, Australia

*Nagesh B. Pai, Illawarra Health Medical Research Institute, University of Wollongong Wollongong 2522, New South Wales, Australia. E-mail: nagesh@uow.edu.au

Publication History

  1. Issue published online: 12 DEC 2011
  2. Article first published online: 24 OCT 2011
  3. Accepted for publication September 13, 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (432K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nancy Légaré, Claire-Anne Grégoire, Luigi De Benedictis, Alexandre Dumais, Increasing the clozapine: Norclozapine ratio with co-administration of fluvoxamine to enhance efficacy and minimize side effects of clozapine therapy, Medical Hypotheses, 2013, 80, 6, 689

    CrossRef

  2. 2
    N. B. Pai, M. Laidlaw, S.-C. Vella, Augmentation of clozapine with another pharmacological agent: treatment for refractory schizophrenia in the ‘real world’, Acta Psychiatrica Scandinavica, 2012, 126, 1
    Direct Link:
  3. 3
    Femi Oyebode, Abhinav Rastogi, Giles Berrisford, Floriana Coccia, Psychotropics in pregnancy: Safety and other considerations, Pharmacology & Therapeutics, 2012, 135, 1, 71

    CrossRef

View Full Article (HTML) Get PDF (432K)